management of thyroid carcinoma: hahnemann experience

the primary treatment of thyroid carcinoma is surgery and the outcome depends on its extent. the post-operative management alternatives in thyroid carcinoma include thyroid hormone, radio-iodine ablation (i-131 na), external beam radiation therapy (ebrt) and occasionally adjuvant chemotherapy. this retrospective study analyzes the managements of 153 patients (102, 51), age range 10-96 years, mean age 50.2 years treated for thyroid carcinoma. the range of follow-up was 1.0-294 months with median follow-up for 60.4 months. twenty patients without therapy were excluded. group a included 87 patients treated with i-131. group b consisted of 13 patients received ebrt. group c included both therapies in 33 patients. the therapies in all different stages of thyroid carcinoma and with various histopathologies were reviewed.